Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy-Reference-Cited by-同舟云学术

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

Published:2008-01 Issue:1 Volume:26 Page:33-38
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Kanemura Nobuhiro,Tsurumi Hisashi,Kasahara Senji,Hara Takeshi,Yamada Toshiki,Sawada Michio,Goto Naoe,Kitagawa Jun-ichi,Shimizu Masahito,Oyama Masami,Moriwaki Hisataka

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference22 articles.

1. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

2. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia

3. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study

4. Acute myeloid leukemia: Epidemiology and etiology

5. Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia;Annals of Hematology;2018-10-19

2. High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia;Leukemia & Lymphoma;2015-06-18

3. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics;Leukemia & Lymphoma;2014-11-03

4. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin;Nanotechnology;2012-09-14

5. Acute Myeloid Leukaemia;Drugs;2011-08